Rasagiline

FDA Drug Profile — Rasagiline, RASAGILINE

Drug Details

Generic Name
Rasagiline
Brand Names
Rasagiline, RASAGILINE
Application Number
NDA021641
Sponsor
Teva Pharmaceuticals USA, Inc.
NDC Codes
15
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
RASAGILINE MESYLATE

Indications and Usage

1. INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson's disease (PD). Rasagiline tablets are monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson's disease ( 1 )